Experienced in Venous Thromboembolism (VTE)

Gwenole Rohel

2 Boulevard Sainte Anne 83000, 
Toulon, FR 
Experienced in Venous Thromboembolism (VTE)
2 Boulevard Sainte Anne 83000, 
Toulon, FR 
OverviewLocationsClinical Research

Overview

Gwenole Rohel practices in Toulon, France. Rohel is rated as an Experienced expert by MediFind in the treatment of Venous Thromboembolism (VTE). Their top areas of expertise are Heart Murmurs, Cerebral Hypoxia, Myocarditis, and Venous Thromboembolism (VTE).

Their clinical research consists of co-authoring 12 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have participated in 2 clinical trials in the study of Venous Thromboembolism (VTE).

Locations

2 Boulevard Sainte Anne 83000, Toulon, 83000, France
Other Locations
Brest, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Enrollment Status: Terminated
Publish Date: October 19, 2022
Intervention Type: Drug
Study Drugs: Apixaban, Rivaroxaban, Heparin, VKA
Study Phase: Phase 3
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
View 1 Less Clinical Trial

12 Total Publications

Ibrutinib-associated atrial fibrillation : A therapeutic challenge
Ibrutinib-associated atrial fibrillation : A therapeutic challenge
Journal: Annales de cardiologie et d'angeiologie
Published: July 17, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rohel's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile